Video Shorts

1:06
Market Watch Rx: Cigna Joins Top Gainers
5 months ago
by
Nicholas Jacobus

1:13
Solving the Healthcare Cost Crisis Through Collective Action
5 months ago
by
Mike Hollan(+1 more)

1:06
Market Watch Rx: Editas Medicine Leads Gainers
5 months ago
by
Nicholas Jacobus

0:46
The First Amendment's Impact on DTC Prescription Drug Ads
5 months ago
by
Mike Hollan(+1 more)

0:38
Improving FDA & Biopharma's Relationship
5 months ago
by
Nicholas Jacobus(+1 more)

0:59
Big Pharma’s Next Big Shift: Rare Diseases vs. Mass Markets
5 months ago
by
Mike Hollan(+1 more)

1:15
Market Watch Rx: Baxter International Leads Gainers
6 months ago
by
Nicholas Jacobus

0:43
FDA's Shift: Why Predictability Now Matters More Than Speed
6 months ago
by
Mike Hollan(+1 more)

0:45
Using Data to Come to the Right Conclusions
6 months ago
by
Mike Hollan(+1 more)

1:12
Market Watch Rx: Humana Leads Top Gainers
6 months ago
by
Nicholas Jacobus

0:53
FDA Leadership Turnover Explained
6 months ago
by
Mike Hollan(+1 more)

1:19
Market Watch Rx: Eli Lilly Joins Top Gainers
6 months ago
by
Nicholas Jacobus

0:49
Why the US Healthcare System is Fragmented
6 months ago
by
Mike Hollan(+1 more)

0:32
Why Patient Care is the Heart of Pharma Business
6 months ago
by
Mike Hollan(+1 more)

1:15
Market Watch Rx: West Pharmaceutical Services Leads Gainers
6 months ago
by
Nicholas Jacobus

0:32
Why 'Just-In-Time' Delivery is a Trap
6 months ago
by
Nicholas Jacobus(+1 more)

0:29
The United State's Regulatory Impact on Global Drug Launches
6 months ago
by
Mike Hollan(+1 more)

1:08
Market Watch Rx: Johnson & Johnson Shares Slide
6 months ago
by
Nicholas Jacobus

0:40
Real Hope: The Best Part of Being an Oncologist
7 months ago
by
Nicholas Jacobus(+1 more)

0:46
How Platform Technologies and Partnerships are Shaping CGT Development
7 months ago
by
Mike Hollan(+1 more)

0:43
Branding's Hidden Power
7 months ago
by
Michael Christel(+1 more)

1:09
Market Watch Rx: Roche Joins Top Gainers
7 months ago
by
Nicholas Jacobus

0:42
Addressing the Biosimilar Void in the U.S. Market
7 months ago
by
Mike Hollan(+1 more)

1:13
Market Watch Rx: Humana Leads Gainers
7 months ago
by
Nicholas Jacobus

0:40
The Relationship Between Muscle Building and GLP-1s
7 months ago
by
Mike Hollan(+1 more)

0:56
Drug Policy Shift: MFN's Impact on Providers
7 months ago
by
Mike Hollan(+1 more)

0:50
The Weird Connection Between Cancer and Heart Attacks
7 months ago

1:01
Market Watch Rx: Merck Joins Top Gainers
7 months ago
by
Nicholas Jacobus

0:50
Why China’s R&D Model is Thriving
7 months ago
by
Michael Christel(+2 more)
Advertisement
Advertisement
Trending on PharmExec
1
Hims & Hers Partners with Eli Lilly to Sell Obesity Medicines
2
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro
3
The US Drug-Pricing Reset: Competing on Net Value
4
Roundup: Boehringer Ingelheim Licenses Six Oncology Programs From Sino Biopharmaceutical, Nxera Licenses EP4 Agonist to AbbVie
5

